CD44 and CD133 cancer stem cell markers as indicators for aggressive ovarian tumours

被引：0
|
作者：
Jovanovic, L.
Sosic-Jurjevic, B.
Cirkovic, A.
Dragicevic, S.
Filipovic, B.
Milenkovic, S.
Dugalic, S.
Gojnic-Dugalic, M.
Nikolic, A.
机构：
来源：
VIRCHOWS ARCHIV | 2024年 / 485卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
E-PS-10-05
引用
收藏
页码：S285 / S285
页数：1
相关论文
共 50 条
  • [41] THE ROLES OF CD44 EXPRESSION AND THE COMBINATION OF CD133, CD44, ALDH1A1 EXPRESSIONS IN CHEMOTHERAPY RESPONSE OF EPITHELIAL TYPE OVARIAN CANCER
    Pelupessy, N.
    Rauf, S.
    Andrijono, A.
    Nuranna, L.
    Sutrisna, B.
    Harahap, A.
    Kanoko, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A49 - A49
  • [42] The utility of CD44, CD117 and CD133 in identification of cancer stem cells (CSC) in oral squamous cell carcinomas (OSCC)
    Margaritescu, Cl
    Pirici, D.
    Simionescu, Cristiana
    Stepan, A.
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2011, 52 (03): : 985 - 993
  • [43] The promotion of nanoparticle delivery to two populations of gastric cancer stem cells by CD133 and CD44 antibodies
    Chen, Han
    Lin, Jiajia
    Shan, Yongqi
    Lu, Zhengmao
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 115
  • [44] Clinicopathological and prognostic significance of cancer stem cell markers CD44 and CD133 in patients with gastric cancer A comprehensive meta-analysis with 4729 patients involved
    Lu, Li
    Wu, Menglin
    Sun, Longhao
    Li, Weidong
    Fu, Weihua
    Zhang, Xuening
    Liu, Tong
    MEDICINE, 2016, 95 (42)
  • [45] Association of cancer stem cell markers CD44 and CD133 expression with clinicopathological changes in Oral squamous cell carcinoma (OSCC) and oral submucosal fibrosis (OSMF)
    Shriddha, Awasthi
    Narain, Srivastava Anand
    Gul, Memon Anjuman
    Shariq, Iqbal Mohammed
    Ausaf, Ahmad
    RESEARCH JOURNAL OF BIOTECHNOLOGY, 2023, 18 (01): : 84 - 93
  • [46] Expression of the potential cancer stem cell markers, CD133, CD44, ALDH1, and β-catenin, in primary lung adenocarcinoma-their prognostic significance
    Okudela, Koji
    Woo, Tetsukan
    Mitsui, Hideaki
    Tajiri, Michihiko
    Masuda, Munetaka
    Ohashi, Kenichi
    PATHOLOGY INTERNATIONAL, 2012, 62 (12) : 792 - 801
  • [47] Effect of EpCAM, CD44, CD133 and CD166 expression on patient survival in tumours of the ampulla of Vater
    Piscuoglio, Salvatore
    Lehmann, Frank S.
    Zlobec, Inti
    Tornillo, Luigi
    Dietmaier, Wolfgang
    Hartmann, Arndt
    Wuensch, Peter H.
    Sessa, Fausto
    Ruemmele, Petra
    Baumhoer, Daniel
    Terracciano, Luigi M.
    JOURNAL OF CLINICAL PATHOLOGY, 2012, 65 (02) : 140 - 145
  • [48] Stem cells in ductal breast cancer: immunohistochemical expression of CD44, CD24, CD133, and ALDH-1 markers in 104 cases
    Korfias, D.
    Contis, J.
    Frangou-Plemenou, M.
    Gennatas, K.
    Kondis, A.
    Vlachodimitropoulos, D.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2020, 41 (01) : 36 - 41
  • [49] COMPARISON OF CD49F, CD44 AND CD133 AS MARKERS OF STEM-LIKE CELLS FROM THE BENIGN HUMAN PROSTATE
    Yamamoto, H.
    Masters, J. R.
    Dasgupta, P.
    Popert, R.
    Chandra, A.
    Freeman, A.
    Patel, H.
    Ahmed, A.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 208 - 208
  • [50] Co-expression of stem cell genes CD133 and CD44 in colorectal cancers with early liver metastasis
    Huang, Xiaodong
    Sheng, Yu
    Guan, Ming
    SURGICAL ONCOLOGY-OXFORD, 2012, 21 (02): : 103 - 107
12345